Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Digital innovation in clinical trials: Strategic implications for drug and device development
In this panel discussion, industry experts Dr. Scott Gottlieb, Joel Haspel, and Shwen Gwee explore the effects and evolution of digital innovation, as well as the regulatory stance on the acceleration and adoption of digital tools in clinical trials.
Related Content
